InsiderTrades

Form 4 for KMX CARMAX INC

Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-30 · accession 0001170010-22-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-01-03 2021-12-30 KMX Wilson Charles Joseph SVP M - OptEx $63.17 +16.1K 26.8K +149% +$1.01M
D 2022-01-03 2021-12-30 KMX Wilson Charles Joseph SVP S - Sale+OE $127.48 -16.1K 11.8K -58% -$2.05M
D 2022-01-03 2021-12-30 KMX Wilson Charles Joseph SVP G - Gift $0.00 -787 11.0K -7% $0
DM 2022-01-03 2021-12-30 KMX Wilson Charles Joseph SVP M - OptEx $0.00 -16.1K 10.0K -62% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-30 M A 994 $65.20 27,827 D — —
2 Common Common Stock 2021-12-30 M A 15,065 $63.04 26,833 D — —
3 Common Common Stock 2021-12-30 S D 16,059 $127.48 11,768 D — — (F1) The shares with respect to this transaction were sold at prices ranging from $127.44 to $127.75. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2021-12-30 G D 787 $0.00 10,981 D — —
5 Derivative Stock Options (Right to Buy) 2021-12-30 M D 994 $0.00 0 D $65.20 · — to 2024-12-27 994 Common Stock (F3) The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of December 27, 2018, December 27, 2019, December 27, 2020 and December 27, 2021.
6 Derivative Stock Options (Right to Buy) 2021-12-30 M D 15,065 $0.00 10,021 D $63.04 · — to 2025-05-01 15,065 Common Stock (F2) The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2019, May 1, 2020, and May 1, 2021 and become exercisable with respect to one-fourth of the underlying shares of Common Stock on May 1, 2022.